SIGYN THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance
SIGYN THERAPEUTICS, INC. (SIGY) had Deferred Tax Assets, Valuation Allowance of $3.96 million as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2025-04-15
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $3.96M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $3.02M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $1.67M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $1.07M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2024-12-31 | $3.96M 10-K · filed 2025-04-15 | |
| 2023-12-31 | $3.02M 10-K · filed 2025-04-15 | |
| 2022-12-31 | $1.67M 10-K · filed 2024-02-20 | |
| 2021-12-31 | $1.07M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $352.91K 10-K · filed 2022-03-21 | |
| 2019-12-31 | $434.00 10-K · filed 2021-04-06 | $5.07M 10-K · filed 2020-03-30 |
| 2018-12-31 | $3.45M 10-K · filed 2020-03-30 | |
| 2017-12-31 | $2.67M 10-K · filed 2019-04-01 | |
| 2015-12-31 | $1.32M 10-K · filed 2016-03-30 | |
| 2014-12-31 | $248.06K 10-K · filed 2016-03-30 |